Innate Pharma (IPHA) Appoints Jonathan Dickinson as CEO and Board Chair

Go back to Innate Pharma (IPHA) Appoints Jonathan Dickinson as CEO and Board Chair
(NASDAQ: IPHA) Delayed: 2.12 +0.05 (2.42%)
Previous Close $2.07    52 Week High
Open $2.11    52 Week Low
Day High $2.13    P/E N/A 
Day Low $2.09    EPS
Volume 27,072